{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:16:34Z","timestamp":1790604994549,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008048","name":"Nanjing University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013059","name":"Jiangsu Provincial Medical Youth Talent","doi-asserted-by":"publisher","award":["QNRC2016327"],"award-info":[{"award-number":["QNRC2016327"]}],"id":[{"id":"10.13039\/501100013059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013059","name":"Jiangsu Provincial Medical Youth Talent","doi-asserted-by":"publisher","award":["QNRC2016328"],"award-info":[{"award-number":["QNRC2016328"]}],"id":[{"id":"10.13039\/501100013059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400963"],"award-info":[{"award-number":["81400963"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.intimp.2022.108755","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T18:05:47Z","timestamp":1649181947000},"page":"108755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Maraviroc, an inhibitor of chemokine receptor type 5, alleviates neuroinflammatory response after cerebral Ischemia\/reperfusion injury via regulating MAPK\/NF-\u03baB signaling"],"prefix":"10.1016","volume":"108","author":[{"given":"Beilei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luhang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6654-7100","authenticated-orcid":false,"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1557-7465","authenticated-orcid":false,"given":"Hailong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.108755_b0005","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/practneurol-2020-002557","article-title":"Diagnosis and management of acute ischaemic stroke","volume":"20","author":"Hurford","year":"2020","journal-title":"Practical neurology"},{"key":"10.1016\/j.intimp.2022.108755_b0010","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1161\/CIRCULATIONAHA.113.001278","article-title":"Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice","volume":"127","author":"Cipriani","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2022.108755_b0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1212\/CON.0000000000000840","article-title":"Update on Treatment of Acute Ischemic Stroke","volume":"26","author":"Rabinstein","year":"2020","journal-title":"Continuum (Minneap Minn)"},{"issue":"2","key":"10.1016\/j.intimp.2022.108755_b0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1517\/14728214.2013.790363","article-title":"Emerging neuroprotective drugs for the treatment of acute ischaemic stroke","volume":"18","author":"Schmidt","year":"2013","journal-title":"Expert Opin. Emerging Drugs"},{"key":"10.1016\/j.intimp.2022.108755_b0025","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.nbd.2009.12.015","article-title":"HIV-1 neuroimmunity in the era of antiretroviral therapy","volume":"37","author":"Kraft-Terry","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2022.108755_b0030","doi-asserted-by":"crossref","first-page":"41772","DOI":"10.1074\/jbc.M110.153460","article-title":"CC chemokine receptor 5 (CCR5) desensitization: cycling receptors accumulate in the trans-Golgi network","volume":"285","author":"Escola","year":"2010","journal-title":"J. biological chem."},{"key":"10.1016\/j.intimp.2022.108755_b0035","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3389\/fimmu.2017.01358","article-title":"The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection","volume":"8","author":"Venuti","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.108755_b0040","doi-asserted-by":"crossref","first-page":"134762","DOI":"10.1016\/j.neulet.2020.134762","article-title":"Activation of AMPK pathway compromises Rab11 downregulation-mediated inhibition of Schwann cell proliferation in a Glut1 and Glut3-dependent manner","volume":"720","author":"Li","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.intimp.2022.108755_b0045","doi-asserted-by":"crossref","first-page":"106138","DOI":"10.1016\/j.intimp.2019.106138","article-title":"Maraviroc attenuates the pathogenesis of experimental autoimmune encephalitis","volume":"80","author":"Karampoor","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2022.108755_b0050","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2147\/DMSO.S236127","article-title":"The Role of JNk Signaling Pathway in Obesity\ufeff-Driven Insulin Resistance","volume":"13","author":"Feng","year":"2020","journal-title":"Diabetes, metabolic syndrome and obesity: targets and therapy"},{"key":"10.1016\/j.intimp.2022.108755_b0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbrc.2014.10.025","article-title":"Perillaldehyde attenuates cerebral ischemia-reperfusion injury-triggered overexpression of inflammatory cytokines via modulating Akt\/JNK pathway in the rat brain cortex","volume":"454","author":"Xu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2022.108755_b0060","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3390\/biom5031938","article-title":"Macrophage Expression of Inflammatory Genes in Response to EMCV Infection","volume":"5","author":"Shaheen","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2022.108755_b0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000353229","article-title":"CCR5 and FPR1 mediate neutrophil recruitment in endotoxin-induced lung injury","volume":"6","author":"Grommes","year":"2014","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.intimp.2022.108755_b0070","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1002\/jcp.26485","article-title":"Effects of treatment with Maraviroc a CCR5 inhibitor on a human hepatic stellate cell line","volume":"233","author":"Coppola","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2022.108755_b0075","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1016\/j.transproceed.2006.10.115","article-title":"A novel CCR5\/CXCR3 antagonist protects intestinal ischemia\/reperfusion injury","volume":"38","author":"Akahori","year":"2006","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.intimp.2022.108755_b0080","doi-asserted-by":"crossref","first-page":"e28499","DOI":"10.1371\/journal.pone.0028499","article-title":"In vitro downregulation of matrix metalloproteinase-9 in rat glial cells by CCR5 antagonist maraviroc: therapeutic implication for HIV brain infection","volume":"6","author":"Gramegna","year":"2011","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.intimp.2022.108755_b0085","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.cyto.2012.12.013","article-title":"Maraviroc reduces cytokine expression and secretion in human adipose cells without altering adipogenic differentiation","volume":"61","author":"D\u00edaz-Delf\u00edn","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2022.108755_b0090","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/jcbfm.2012.88","article-title":"Inflammatory cytokines in experimental and human stroke Journal of cerebral blood flow and metabolism","volume":"32","author":"Lambertsen","year":"2012","journal-title":"official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.intimp.2022.108755_b0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4155\/tde-2019-0075","article-title":"Targeting the NF-\u03baB pathway for therapy of ischemic stroke","volume":"11","author":"Howell","year":"2020","journal-title":"Therapeutic delivery"},{"key":"10.1016\/j.intimp.2022.108755_b0100","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3349\/ymj.2015.56.4.1134","article-title":"Chemokine Signaling Pathway Involved in CCL2 Expression in Patients with Rheumatoid Arthritis","volume":"56","author":"Zhang","year":"2015","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.intimp.2022.108755_b0105","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1128\/AAC.49.11.4721-4732.2005","article-title":"Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity","volume":"49","author":"Dorr","year":"2005","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922002399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922002399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:42:17Z","timestamp":1761586937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922002399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":21,"alternative-id":["S1567576922002399"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108755","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maraviroc, an inhibitor of chemokine receptor type 5, alleviates neuroinflammatory response after cerebral Ischemia\/reperfusion injury via regulating MAPK\/NF-\u03baB signaling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108755"}}